Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Q2 2025 Earnings Call Transcript August 11, 2025
Arcturus Therapeutics Holdings Inc. beats earnings expectations. Reported EPS is $-0.34, expectations were $-1.11.
Operator: Good day, everyone, and welcome to the Arcturus Therapeutics Second Quarter 2025 Earnings Call. [Operator Instructions] Please note this call is being recorded. It is now my pleasure to turn the conference over to Neda Safarzadeh, Vice President, Head of Investor...
